Learn more about Elegen’s superior ability to produce high-complexity DNA sequences that conventional methods struggle with. Our novel assembly method minimizes hybridization errors during polymerase chain assembly (PCA), enabling the successful synthesis of sequences rich in GC-rich elements, long repeats, and other challenging structures that are frequently rejected by competitors, including:
Internal testing demonstrates significantly improved synthesis success rates (92%) compared to leading competitors (≤58%), validating ENFINIA’s ability to handle previously unsynthesizable sequences, such as those found in antibody expression constructs and various promoters.